How much does peptide therapy cost in Australia?
Short answer: $99 for the AHPRA telehealth consult plus $90-$260 per compounded vial from a TGA-licensed Australian pharmacy. Not covered by Medicare or most private health funds.
Full breakdown below by peptide. All pricing is 2026 indicative and confirmed by your prescriber before any vial is compounded.
What you're actually paying for
Legitimate peptide therapy in Australia has two separate costs: (1) the AHPRA-registered Australian doctor's consult — $99 at PeptideDoctorAU, includes the TGA SAS-B notification; and (2) the compounded vial from a TGA-licensed Australian compounding pharmacy — charged at cost by the pharmacy, billed separately, varies by peptide. There is no third 'membership' fee. Repeat consults for ongoing prescriptions are typically $59-$79.
Indicative vial pricing (2026)
These are typical ranges from TGA-licensed Australian compounding pharmacies in 2026 — your prescriber will confirm exact pricing: • BPC-157 — $120-$180 per vial • CJC-1295 + Ipamorelin blend — $140-$210 • Ipamorelin alone — $130-$190 • GHK-Cu (injectable) — $110-$170 • MOTS-c — $190-$260 • AOD-9604 — $130-$200 • Tirzepatide (ARTG, private) — $300-$600 per month • Semaglutide (ARTG, private) — $280-$520 per month
Why offshore 'research chemical' vials are not actually cheaper
A $40 offshore vial looks cheaper than a $150 Australian compounded vial — until you factor in: customs seizure risk (the shipment is unlawful), no batch testing for identity / sterility / potency, no Australian doctor to call for side effects, and personal legal exposure under the Customs Act and Poisons Standard. The TGA-licensed pathway costs more because real quality control and real clinical oversight cost more.
FAQs
- How much does peptide therapy cost in Australia in 2026?
- Expect $99 for the AHPRA telehealth consult, plus $90 to $260 per compounded vial depending on the peptide and dose. Most patients spend $200 to $400 in their first month including consult and one vial.
- Is peptide therapy covered by Medicare?
- No. Peptides accessed under TGA SAS-B are not on the Pharmaceutical Benefits Scheme (PBS) and the telehealth consult is private. Tirzepatide and semaglutide are ARTG-registered but PBS subsidy is restricted to specific clinical criteria.
- Is peptide therapy covered by private health insurance?
- Generally no. Most extras policies do not cover compounded peptides or SAS-B consults. Check your specific policy before assuming any rebate.
- How much does BPC-157 cost in Australia?
- Compounded BPC-157 typically costs $120 to $180 per vial in 2026 from a TGA-licensed Australian compounding pharmacy. A typical 4-week course is one vial.
- How much does tirzepatide cost in Australia?
- Tirzepatide (Mounjaro) private pricing varies by pen strength but typically falls between $300 and $600 per month at 2026 list prices. PBS-subsidised access exists only for narrow clinical criteria.
- Why is the consult $99 instead of free?
- TGA SAS-B prescribing requires a real clinical assessment by an AHPRA-registered doctor, not a tick-box order form. The $99 covers the consult and SAS-B lodgement; the pharmacy charges separately for the compounded medicine. There is no subscription or hidden fee.
Related reading
Medically reviewed by the PeptideDoctorAU Medical Review Panel — last reviewed 29 May 2026. See the panel.
Start lawfully — $99 telehealth consult
Free 5-minute pre-qualification. If suitable, you'll be matched with an AHPRA-registered Australian doctor — TGA SAS-B prescribing, Australian-compounded vial.
Start free assessment